Using a hollow microstructured transdermal system to deliver vaccine directly to the dermis.
Mark Tomai
Advertisement
Articles by Mark Tomai
The role of TLR agonists has expanded, and now the molecules can be found in a variety of non-vaccine therapeutics.
Advertisement
Latest Updated Articles
Toll-Like Receptor Agonists: Not Just for Vaccines AnymorePublished: January 2nd 2011 | Updated:
Optimizing a Unique Cancer Vaccine for Intradermal DeliveryPublished: September 15th 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
How Enzymatic Platforms May Change the Therapeutic RNA Supply Chain
2
Q&A: Strategies for Supply Chain Resilience and Next-Generation Process Optimization
3
BioPharm Weekly News Roundup—Week of Oct. 27, 2025
4
BioPharma By the Numbers: Bioprocess Hiring Creating Capacity Constraints
5
